CHANDA NUNNENKAMP: Open Payments
NPI 1235755182 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 84 payments from 24 companies in 2025. Trend: 2023 $883 · 2024 $1,228 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $411 |
| Astellas Pharma US Inc | 7 | $238 |
| PFIZER INC. | 12 | $200 |
| Novo Nordisk Inc | 7 | $126 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Lilly USA, LLC | 4 | $58 |
| Tonix Medicines, Inc. | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Organon LLC | 2 | $34 |
Products named: VRAYLAR, Veozah, NURTEC ODT, UBRELVY, QULIPTA, REXULTI, Wegovy, MOUNJARO.
Industry payments across NE — which companies pay providers there.
